Sat. November 21, 2009
-
HemOncToday
November 19, 2009
In January, the FDA alerted
health care professionals that published reports revealed that clopidogrel (Plavix; Sanofi Aventis, Bristol-Myers Squibb) is ...
Reuters
November 19, 2009
N) and
Sanofi-Aventis (SASY.PA).
analysts see Brilinta as a potential multibillion-dollar a year seller for
AstraZeneca, which plans to file an application ...
FavStocks (blog)
November 19, 2009
Exelixis has entered into a
global license agreement with
Sanofi-Aventis for XL147. Exelixis' President of Research and Development, Michael M. Morrissey ...
East Bay Business Times
November 19, 2009
That is comparable to the 7.0-month median demonstrated by patients in the trial who were given Eloxatin, a Sanofi-Aventis chemotherapy drug. ...
Business Intelligence Middle East (press release)
November 19, 2009
The event, in collaboration with
Sanofi-Aventis, is also in line with the partnership between
private and
public institutions to promote health services. ...
The Money Times
November 19, 2009
While the confusion over the combined use of the two classes of drugs is not new, the recent trials conducted by Plavix's manufacturer Sanofi-Aventis and ...
MarketWatch
November 19, 2009
London (marketwatch) -- French drugmaker Sanofi-Aaventis (
Paris:FR:SAN) (
NYSE:SNY) and Medicines for Malaria Venture will launch the largest safety and ...
pharmabiz.com
November 17, 2009
Sanofi-Aventis announced the launch of the RealiseAF registry (Real Life
global Survey Evaluating patients with Atrial Fibrillation), an international, ...
4-traders (press release)
November 17, 2009
Sanofi-Aventis is listed in
Paris (EURONEXT: SAN) and in New York (
NYSE: SNY). (1) Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial (2) ...
Reuters India
November 17, 2009
London, Nov 17 (Reuters) - French drugmaker
Sanofi-Aventis (SASY.PA: Quote, Profile, Research) sees major growth drivers in
China and
India ...
FierceBiotech
November 17, 2009
The Phase II results showed that the drug was comparable to Eloxatin, an approved chemotherapy marketed by Sanofi-Aventis. The company also revealed ...
Seeking Alpha (blog)
November 17, 2009
We would like to believe that our initial parallel between buying AOB and Berkshire Hathaway's long-standing investment in Sanofi-Aventis (SNY) holds true: ...
Motley Fool
November 17, 2009
After spending the last several months at a four-star rank, enough top-performing CAPS members have turned bullish on
Sanofi-Aventis (
NYSE: SNY) recently to ...
ABC News
November 17, 2009
WASHINGTON (Reuters) - Common heartburn pills Prilosec and Nexium cut the blood-thinning effect of Sanofi-Aventis SA's and Bristol-Myers ...
SYS-CON Media (press release)
November 16, 2009
"
Sanofi-Aventis is a major contributor to the efforts to reduce the
public health burden of atrial fibrillation," said Jean-Pierre Lehner , Chief Medical ...
Reuters
November 16, 2009
The study was designed to see if the addition of Plavix -- already a $9 billion a year seller for Bristol-Myers Squibb Co and Sanofi Aventis -- to standard ...
WHO says
Glaxo,
Sanofi-Aventis, MedImmune and CSLhave so far promised to donate a total of 156 million doses of vaccine against the A(H1N1) pandemic strain ...
RTT News
November 9, 2009
Cefotaxime injection is generic equivalent to Claforan injection of Sanofi Aventis
Zacks.com
November 9, 2009
We are pleased with Micromet's collaboration agreement with Sanofi-Aventis
Zacks.com
November 9, 2009
Zacks.com
November 9, 2009
The narrower loss reflected the increased contract research and development revenues from its collaborations with Sanofi-Aventis
Reuters
November 9, 2009
...
The
Hong Kong government announced it paid HK$237 million to French pharmaceutical firm
Sanofi-Aventis Group for 3 million A(H1N1)
flu vaccines
Thursday. ...
Reuters
November 5, 2009
These forward-looking statements include statements regarding the operation of the
global collaboration with
Sanofi-Aventis
RTT News
November 4, 2009
Total said its share of adjustments and selected items in connection with Sanofi-Aventis
EasyBourse.com
November 4, 2009
Paris -(Dow Jones)- French oil major Total sa's (TOT) stake in
Sanofi-Aventis
Reuters
November 4, 2009
Sanofi-Aventis
Business Wire (press release)
November 4, 2009
It excludes the after-
tax inventory effect, special items, and the Group's equity share of adjustments and selected items related to
Sanofi-Aventis
Reuters
November 3, 2009
Regeneron and Sanofi-Aventis
Reuters
November 2, 2009
About Sanofi-Aventis Sanofi-Aventis
Reuters
November 2, 2009
2 /PRNewswire/ -- Prasco Laboratories announced today that it has entered into agreements with Winthrop US, a business of Sanofi-Aventis
Reuters
October 30, 2009
In the third quarter of 2009, Sanofi-Aventis
Oct. 30 (Bloomberg) --
Sanofi-Aventis SA,
France's largest drugmaker, said third-quarter profit climbed 16 percent, lifted by the ...
Oct. 30 (Bloomberg) --
Sanofi-Aventis SA,
France's largest drugmaker, said third-quarter profit climbed 16 percent, lifted by the ...
Oct. 30 (Bloomberg) --
Sanofi-Aventis SA,
France's largest drugmaker, said third-quarter profit climbed 16 percent, lifted by the ...
... beating
analyst' expectations by a wide margin as a new generic version of a
Sanofi-Aventis SA (SNY, SAN.FR) colon-
cancer drug quickly ramped up sales. ...
NJBIZ
October 27, 2009
After Fran Hahn, of Sanofi-Aventis, asked about what Christie would do to attract and retain businesses, he said he would be personally involved in the ...
Trading Markets (press release)
October 27, 2009
Since then, Sanofi-Aventis has returned 20.8% as of today's recent price of $38.69. Want to profit from these alerts? Go to www.mysmartrend.com now for a ...
Trading Markets (press release)
October 27, 2009
Williams is the former chairman and
CEO of Sanofi Pasteur, the vaccine business of
Sanofi-Aventis Group.
wells is a senior member of the Biologics ...
